Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...

Weight loss drugs can cause side effects including nausea, vomiting, diarrhoea, haemorrhoids and constipation, which can ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with T2D.

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

If you’re taking a GLP-1 medication, such as semaglutide (Ozempic or Wegovy), exercise is an essential part of your routine — and not just for weight loss reasons. “Exercise helps you maintain muscle ...

The first step of setting up a new device starts with cleaning up your old phone. If you’re planning on trading in your old ...

AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...

Years ago, Robyn Munsch would wander hungrily around the grocery store and leave with calorie-dense foods like a frozen pizza ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

In its first-quarter 2025 investor letter, Mar Vista U.S. Quality Select Strategy highlighted stocks such as PepsiCo, Inc.